Atika Capital Management LLC
Position in TARS — Tarsus Pharmaceuticals, Inc.
CIK 1599731
NEW YORK, NY
Position in TARS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,517,598
-$4,900,229 QoQ
Shares Held
40,000
-72.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#93
of 256 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $149,589,314 across 18 Biotechnology names. TARS ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
88,000 | $16,480,639 | |
| 2 | ASND |
Ascendis Pharma A/S
|
61,000 | $16,269,919 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
165,000 | $16,084,198 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
63,000 | $15,420,508 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
104,000 | $11,925,678 | |
| 6 | TWST |
Twist Bioscience Corp
|
108,000 | $11,111,039 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
272,000 | $10,526,399 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
100,000 | $9,516,998 |
All Filings in TARS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,517,598 | 40,000 | Shares | Defined | 2026-08-13 | |
| 2025-03-31 | $7,417,827 | 144,400 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $9,811,562 | 177,200 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||